: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Influenza

Free Subscription

Articles published in N Engl J Med
Retrieve available abstracts of 774 articles:
HTML format

Single Articles

September 2023

BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
N Engl J Med. 2023;389:1085-1095.
PubMed Abstract available

August 2023

MURRAY EJ, Cowger TL, Hall KT
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
N Engl J Med. 2023;389:580.
PubMed

MARINE JE
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
PubMed

LADHANI SN, Andrews N, Ramsay ME
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
PubMed

RUSSELL FM, Curtis N, Carlin J
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:578-579.
PubMed

KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
N Engl J Med. 2023;389:474-475.
PubMed

July 2023

BECERRA X, Jha A
Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
PubMed

ARBEL R, Sergienko R, Netzer D, Hammerman A, et al
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply.
N Engl J Med. 2023;389:285-286.
PubMed

HOEG TB, Duriseti R, Prasad V
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19.
N Engl J Med. 2023;389:284-285.
PubMed

MCCRINDLE BW, Manlhiot C
More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome. Reply.
N Engl J Med. 2023;389:287-288.
PubMed

XIA CY, Niu MM, Hu P
More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
N Engl J Med. 2023;389:287.
PubMed

PITTET LF, Messina NL, Curtis N
BCG to Protect against Covid-19 in Health Care Workers. Reply.
N Engl J Med. 2023;389:192.
PubMed

BENN CS, Netea MG, Aaby P
BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191-192.
PubMed

LOPEZ-CAMPOS GH, Valvano MA
BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191.
PubMed

June 2023

HALABI S, Wilder R, Gostin LO, Hurtado ML, et al
Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention, Preparedness, and Response.
N Engl J Med. 2023;388:2401-2404.
PubMed

CAO Z, Gao Y, Zhao R
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
N Engl J Med. 2023;388:2396-2397.
PubMed

LI Y
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2396.
PubMed

EDWARDS JL
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395-2396.
PubMed

BERGMANN F, Jorda A, Zeitlinger M
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395.
PubMed

LIN DY, Fleming TR
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395.
PubMed

MCGARRY BE, Gandhi AD, Barnett ML
Covid-19 Surveillance Testing in Nursing Homes. Reply.
N Engl J Med. 2023;388:2207-2208.
PubMed

STALL NM, Kain DC, Johnstone J
Covid-19 Surveillance Testing in Nursing Homes.
N Engl J Med. 2023;388:2207.
PubMed

DORFMAN D, Berger Z
Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.
N Engl J Med. 2023;388:2115-2117.
PubMed

NIKOLICH JZ, Rosen CJ
Toward Comprehensive Care for Long Covid.
N Engl J Med. 2023;388:2113-2115.
PubMed

GOSTIN LO, Gronvall GK
The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081.
PubMed

TSUBOI M, Herbst RS, John T, Kato T, et al
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594.
PubMed Abstract available

REIS G, Mills EJ, Glenn JS
Pegylated Interferon Lambda for Covid-19. Reply.
N Engl J Med. 2023;388:2108.
PubMed

WANG M, Tang L, Huang L
Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107-2108.
PubMed

ANDREAKOS E, Tsiodras S
Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107.
PubMed

May 2023

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Lasting Effects of Covid-19.
N Engl J Med. 2023;388:e76.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Ending the Covid-19 Emergency.
N Engl J Med. 2023;388:e72.
PubMed

LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
N Engl J Med. 2023;388:1680-1691.
PubMed Abstract available

April 2023

PITTET LF, Messina NL, Orsini F, Moore CL, et al
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;388:1582-1596.
PubMed Abstract available

KARRON RA
RSV Illness in the Young and the Old - The Beginning of the End?
N Engl J Med. 2023;388:1522-1524.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: When to Get a Second Covid-19 Booster Shot.
N Engl J Med. 2023;388:e64.
PubMed

ADAMS G, Moreno GK, Petros BA, Uddin R, et al
Viral Lineages in the 2022 RSV Surge in the United States.
N Engl J Med. 2023;388:1335-1337.
PubMed

KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480.
PubMed Abstract available

MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773.
PubMed

WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836.
PubMed Abstract available

March 2023

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Ending the Covid-19 Public Health Emergency.
N Engl J Med. 2023;388:e53.
PubMed

JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
PubMed

NEUZIL KM
An mRNA Influenza Vaccine - Could It Deliver?
N Engl J Med. 2023;388:1139-1141.
PubMed

MCGARRY BE, Gandhi AD, Barnett ML
Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
N Engl J Med. 2023;388:1101-1110.
PubMed Abstract available

MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al
SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Future of Covid-19 Research.
N Engl J Med. 2023;388:e39.
PubMed

MANSOUR MK, King JD, Chen ST, Fishman JA, et al
Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
N Engl J Med. 2023;388:926-937.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Path Forward for Covid-19 Therapeutics.
N Engl J Med. 2023;388:e36.
PubMed

OFFIT PA
Bivalent Covid-19 Vaccines. Reply.
N Engl J Med. 2023;388:10.
PubMed

MARKS PW, Califf RM
Bivalent Covid-19 Vaccines.
N Engl J Med. 2023;388:10.
PubMed

LI D, Duan M, Wang X, Gao P, et al
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233.
PubMed

February 2023

RUBIN EJ, Baden LR, Graham BS, Morrissey S, et al
Audio Interview: What to Expect from Covid-19 Vaccines.
N Engl J Med. 2023;388:e23.
PubMed

MUNOZ FM, Sher LD, Sabharwal C, Gurtman A, et al
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med. 2023;388:621-634.
PubMed Abstract available

FALSEY AR, Williams K, Gymnopoulou E, Bart S, et al
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
N Engl J Med. 2023;388:609-620.
PubMed Abstract available

PAPI A, Ison MG, Langley JM, Lee DG, et al
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
N Engl J Med. 2023;388:595-608.
PubMed Abstract available

GRAHAM BS
The Journey to RSV Vaccines - Heralding an Era of Structure-Based Design.
N Engl J Med. 2023;388:579-581.
PubMed

CHEMAITELLY H, Tang P, Coyle P, Yassine HM, et al
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med. 2023;388:665-667.
PubMed

HUTH L, Schafer L, Almanzar G, Lupoli G, et al
Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
PubMed

REIS G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, et al
Early Treatment with Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:518-528.
PubMed Abstract available

WANG Q, Bowen A, Valdez R, Gherasim C, et al
Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.
N Engl J Med. 2023;388:567-569.
PubMed

EL-SADR WM, Vasan A, El-Mohandes A
Facing the New Covid-19 Reality.
N Engl J Med. 2023;388:385-387.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Updating and Standardizing Covid-19 Vaccines.
N Engl J Med. 2023;388:e21.
PubMed

January 2023

Covid Vaccines - Playing the Long Game.
N Engl J Med. 2023;388:e5.
PubMed

ZOU J, Kurhade C, Patel S, Kitchin N, et al
Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Weighing the Protective Value of Covid-19 Infection.
N Engl J Med. 2023;388:e13.
PubMed

WINOKUR P, Gayed J, Fitz-Patrick D, Thomas SJ, et al
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med. 2023;388:214-227.
PubMed Abstract available

MILLER J, Hachmann NP, Collier AY, Lasrado N, et al
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.
N Engl J Med. 2023 Jan 18. doi: 10.1056/NEJMc2214314.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccines and New Viral Variants.
N Engl J Med. 2023;388:e8.
PubMed

SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2210825.
PubMed

OFFIT PA
Bivalent Covid-19 Vaccines - A Cautionary Tale.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMp2215780.
PubMed

COLLIER AY, Miller J, Hachmann NP, McMahan K, et al
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2213948.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19.
N Engl J Med. 2023;388:e7.
PubMed

IMAI M, Ito M, Kiso M, Yamayoshi S, et al
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
N Engl J Med. 2023;388:89-91.
PubMed

December 2022

ARBEL R, Wolff Sagy Y, Hammerman A
Nirmatrelvir Use during the Omicron Surge. Reply.
N Engl J Med. 2022;387:2480-2481.
PubMed

WEISS G
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2480.
PubMed

NIELD B
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2479-2480.
PubMed

SWETS MC, de Boer MGJ, Groeneveld GH
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2479.
PubMed

CAO Z, Gao W, Bao H, Feng H, et al
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2022 Dec 28. doi: 10.1056/NEJMoa2208822.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Potential Covid Vaccine Strategies.
N Engl J Med. 2022;387:e75.
PubMed

REIS G, Mills EJ
Ivermectin Treatment for Covid-19. Reply.
N Engl J Med. 2022;387:e66.
PubMed

BARUS R, Gautier S, Wabont G
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

MEJIA JH, Jimenez CA
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

FURLAN L
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

BRAMANTE CT, Buse JB, Boulware DR
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
N Engl J Med. 2022;387:e65.
PubMed

SHUKLA AK, Misra S
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022;387:e65.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19.
N Engl J Med. 2022;387:e74.
PubMed

GILBERT PB, Donis RO, Koup RA, Fong Y, et al
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines.
N Engl J Med. 2022;387:2203-2206.
PubMed

RUBIN EJ, Baden LR, Hlatshwayo Davis M, Morrissey S, et al
Audio Interview: Covid-19 and Health Equity.
N Engl J Med. 2022;387:e73.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Five Disease Outbreaks beyond Covid-19.
N Engl J Med. 2022;387:e68.
PubMed

TAKASHITA E, Yamayoshi S, Halfmann P, Wilson N, et al
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
N Engl J Med. 2022;387:2094-2097.
PubMed

November 2022

ABERG M, Smed-Sorensen A, Thalin C
Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply.
N Engl J Med. 2022;387:e55.
PubMed

ZUO F, Marcotte H, Hammarstrom L, Pan-Hammarstrom Q, et al
Mucosal IgA against SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022;387:e55.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Making Choices about Covid-19.
N Engl J Med. 2022;387:e64.
PubMed

RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
Audio Interview: The FDA and Covid-19 Vaccines.
N Engl J Med. 2022;387:e60.
PubMed

GOLDEN MR, Wasserheit JN
Monkeypox - A Sobering Sentinel for Pandemic Preparedness and Sexual Health System Capacity.
N Engl J Med. 2022;387:1826-1829.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Masking and Covid-19.
N Engl J Med. 2022;387:e56.
PubMed

VENKATARAMANI V, Winkler F
Cognitive Deficits in Long Covid-19.
N Engl J Med. 2022;387:1813-1815.
PubMed

FRICCHIONE GL, Paul AB, Chemali Z, Kritzer MD, et al
Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions.
N Engl J Med. 2022;387:1795-1803.
PubMed

RAIFMAN J, Green T
Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMe2213556.
PubMed

COWGER TL, Murray EJ, Clarke J, Bassett MT, et al
Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMoa2211029.
PubMed Abstract available

CANETTI M, Barda N, Gilboa M, Indenbaum V, et al
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMc2211283.
PubMed

CHESKES S, Verbeek PR, Drennan IR, McLeod SL, et al
Defibrillation Strategies for Refractory Ventricular Fibrillation.
N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2207304.
PubMed Abstract available

RUBIN EJ, Baden LR, Hardin CC, Morrissey S, et al
Audio Interview: Caring for Hospitalized Patients with Covid-19.
N Engl J Med. 2022;387:e51.
PubMed

CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
PubMed Abstract available

October 2022

EMANUEL EJ, Upshur REG, Smith MJ
What Covid Has Taught the World about Ethics.
N Engl J Med. 2022;387:1542-1545.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
N Engl J Med. 2022;387:e50.
PubMed

CHIN ET, Leidner D, Lamson L, Lucas K, et al
Protection against Omicron from Vaccination and Previous Infection in a Prison System.
N Engl J Med. 2022 Oct 26. doi: 10.1056/NEJMoa2207082.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19: Where Are We Heading?
N Engl J Med. 2022;387:e47.
PubMed

ANDERSON EJ, Creech CB, Berthaud V, Piramzadian A, et al
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMoa2209367.
PubMed Abstract available

WITBERG G, Magen O, Hoss S, Talmor-Barkan Y, et al
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2207270.
PubMed

HACHMANN NP, Miller J, Collier AY, Barouch DH, et al
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2212117.
PubMed

RUBIN EJ, Baden LR, Neuzil KM, Morrissey S, et al
Audio Interview: Developing New Covid-19 Vaccines.
N Engl J Med. 2022;387:e44.
PubMed

CHEMAITELLY H, Ayoub HH, Tang P, Hasan MR, et al
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
N Engl J Med. 2022 Oct 12. doi: 10.1056/NEJMc2211055.
PubMed

ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Hasan MR, et al
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMc2209306.
PubMed

September 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Assessing Bivalent Vaccines against Covid-19.
N Engl J Med. 2022;387:e37.
PubMed

TAKASHITA E, Yamayoshi S, Fukushi S, Suzuki T, et al
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
N Engl J Med. 2022;387:1236-1238.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
N Engl J Med. 2022;387:e30.
PubMed

THURNER L, Kessel C, Fadle N, Regitz E, et al
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
N Engl J Med. 2022 Sep 21. doi: 10.1056/NEJMc2205667.
PubMed

CHALKIAS S, Harper C, Vrbicky K, Walsh SR, et al
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
N Engl J Med. 2022 Sep 16. doi: 10.1056/NEJMoa2208343.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Developing Mucosal Immunity to Covid-19.
N Engl J Med. 2022;387:e29.
PubMed

HAVERVALL S, Marking U, Svensson J, Greilert-Norin N, et al
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2209651.
PubMed

COLLIE S, Nayager J, Bamford L, Bekker LG, et al
Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
PubMed

SHEN X, Chalkias S, Feng J, Chen X, et al
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
N Engl J Med. 2022 Sep 9. doi: 10.1056/NEJMc2210648.
PubMed

SULLIVAN DJ, Gebo KA, Hanley DF
Convalescent Plasma for Covid-19. Reply.
N Engl J Med. 2022;387:955-956.
PubMed

PANETH N
Convalescent Plasma for Covid-19.
N Engl J Med. 2022;387:955.
PubMed

JOYNER MJ, Pirofski LA
Convalescent Plasma for Covid-19.
N Engl J Med. 2022;387:955.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Rolling Out New Covid-19 Vaccines.
N Engl J Med. 2022;387:e26.
PubMed

CHARNESS ME, Gupta K, Stack G, Strymish J, et al
Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
PubMed

ANDERSON AS, Caubel P, Rusnak JM
Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
PubMed

LIN DY, Gu Y, Xu Y, Zeng D, et al
Effects of Vaccination and Previous Infection on Omicron Infections in Children.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2209371.
PubMed

QU P, Faraone JN, Evans JP, Zheng YM, et al
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2210546.
PubMed

DUPONT SC, Galea S
Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
PubMed

RUBIN EJ, Baden LR, Swaminathan S, Morrissey S, et al
Audio Interview: Covid-19 and the WHO.
N Engl J Med. 2022;387:e24.
PubMed

August 2022

BAROUCH DH
Covid-19 Vaccines - Immunity, Variants, Boosters.
N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
PubMed

MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
PubMed

MACDONALD SM, Berv J
Losing Contact - Covid-19, Telemedicine, and the Patient-Provider Relationship.
N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2206471.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Choosing an Antiviral to Treat Covid-19.
N Engl J Med. 2022;387:e22.
PubMed

ARBEL R, Wolff Sagy Y, Hoshen M, Battat E, et al
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
N Engl J Med. 2022 Aug 24. doi: 10.1056/NEJMoa2204919.
PubMed Abstract available

ABDOOL KARIM SS, Devnarain N
Time to Stop Using Ineffective Covid-19 Drugs.
N Engl J Med. 2022;387:654-655.
PubMed

BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022;387:599-610.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Combating Covid-19 Today and Tomorrow.
N Engl J Med. 2022;387:e17.
PubMed

JOST TS
Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and Possible Solutions.
N Engl J Med. 2022;387:481-483.
PubMed

KOHANE I, Omenn GS
Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
N Engl J Med. 2022;387:e16.
PubMed

TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
N Engl J Med. 2022;387:468-470.
PubMed

July 2022

RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
N Engl J Med. 2022;387:e13.
PubMed

RUBIN EJ, Baden LR, Jha A, Morrissey S, et al
Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
N Engl J Med. 2022;387:e11.
PubMed

HAMMOND J, Bao W, Simon-Campos A
Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
N Engl J Med. 2022;387.
PubMed

MORRIS AM, Lee TC
Nirmatrelvir for Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022;387.
PubMed

CHEN BS, Hung CH, Wei JC
Nirmatrelvir for Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022;387.
PubMed

TAN SHX, Cook AR, Heng D, Ong B, et al
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
PubMed Abstract available

MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
PubMed

RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
Audio Interview: Covid-19 Vaccines and the FDA.
N Engl J Med. 2022;387:e10.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Designing the Next Covid-19 Vaccine.
N Engl J Med. 2022;387:e6.
PubMed

ZHAO X, Zhang R, Qiao S, Wang X, et al
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
N Engl J Med. 2022 Jul 6. doi: 10.1056/NEJMc2206900.
PubMed

June 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Effective is Covid-19 Vaccination in Children?
N Engl J Med. 2022;386:e78.
PubMed

WAXMAN JG, Magen O, Hernan MA
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med. 2022;387.
PubMed

TUMMINIA A, Romano M
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2022;387.
PubMed

COHEN-STAVI CJ, Magen O, Barda N, Yaron S, et al
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMoa2205011.
PubMed Abstract available

BOUCAU J, Marino C, Regan J, Uddin R, et al
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2202092.
PubMed

LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
PubMed

SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
SARS-CoV-2 Infection in Patients with a History of VITT.
N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinating Young Children against Covid-19.
N Engl J Med. 2022;386:e77.
PubMed

GRIFFIN MR
A Challenge to Respiratory Syncytial Virus Illness in Adults.
N Engl J Med. 2022;386:2427-2428.
PubMed

SCHMOELE-THOMA B, Zareba AM, Jiang Q, Maddur MS, et al
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med. 2022;386:2377-2386.
PubMed Abstract available

HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
PubMed

DESILVA M, Haapala J, Vazquez-Benitez G, Vesco KK, et al
Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
PubMed

HALASA NB, Olson SM, Staat MA, Newhams MM, et al
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
PubMed Abstract available

RASMUSSEN SA, Jamieson DJ
Covid-19 Vaccination during Pregnancy - Two for the Price of One.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
PubMed

RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
N Engl J Med. 2022;386:e75.
PubMed

LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
Association between Covid-19 Vaccination and Influenza Vaccination Rates.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
PubMed

QU P, Faraone J, Evans JP, Zou X, et al
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
PubMed

HOPKINS S, Hall V, Klenerman P
Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
N Engl J Med. 2022;386.
PubMed

MATUCHANSKY C
Protection against SARS-CoV-2 after Vaccination and Previous Infection.
N Engl J Med. 2022;386.
PubMed

ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting the Immunocompromised from Covid-19.
N Engl J Med. 2022;386:e71.
PubMed

ABRAHAM J
Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
N Engl J Med. 2022;386:2236-2238.
PubMed

JOLOBE OMP
Protection Due to Previous SARS-CoV-2 Infection.
N Engl J Med. 2022;386.
PubMed

SCHERER EM, Babiker A, Adelman MW, Allman B, et al
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
PubMed

RUBIN EJ, Baden LR, Moore PL, Morrissey S, et al
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
N Engl J Med. 2022;386:e69.
PubMed

May 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Waning Immunity against Covid-19.
N Engl J Med. 2022;386:e64.
PubMed

GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMoa2118946.
PubMed Abstract available

ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What to Make of Covid-19 Hot Spots.
N Engl J Med. 2022;386:e63.
PubMed

BROWN PE, Fu SH, Bansal A, Newcombe L, et al
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2202879.
PubMed

EVANS JP, Qu P, Zeng C, Zheng YM, et al
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2205019.
PubMed

RUBIN EJ, Baden LR, Lipsitch M, Morrissey S, et al
Audio Interview: Forecasting the Future of Covid.
N Engl J Med. 2022;386:e58.
PubMed

CREECH CB, Anderson E, Berthaud V, Yildirim I, et al
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
N Engl J Med. 2022 May 11. doi: 10.1056/NEJMoa2203315.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Need New Covid-19 Vaccines?
N Engl J Med. 2022;386:e52.
PubMed

ESTCOURT L, Callum J
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
N Engl J Med. 2022;386:1753-1754.
PubMed

HAGER KJ, Perez Marc G, Gobeil P, Diaz RS, et al
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
PubMed Abstract available

DAI L, Gao L, Tao L, Hadinegoro SR, et al
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
PubMed Abstract available

NOHYNEK H, Wilder-Smith A
Does the World Still Need New Covid-19 Vaccines?
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
PubMed

GRAY G, Collie S, Goga A, Garrett N, et al
Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
PubMed

PERSAD G, Pandya A
A Comprehensive Covid-19 Response - The Need for Economic Evaluation.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
PubMed

April 2022

RUBIN EJ, Baden LR, Marrazzo JM, Morrissey S, et al
Audio Interview: Communicating Covid-19 Science.
N Engl J Med. 2022;386:e53.
PubMed

SIMOES EAF, Center KJ, Tita ATN, Swanson KA, et al
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
N Engl J Med. 2022;386:1615-1626.
PubMed Abstract available

RUBIN EJ, Baden LR, Inglefinger JR, Morrissey S, et al
Audio Interview: The Effects of Covid-19 on Children.
N Engl J Med. 2022;386:e51.
PubMed

BHATTACHARYYA RP, Hanage WP
Intrinsic Severity of the SARS-CoV-2 Omicron Variant. Reply.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed

SHAFER SL
Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed

LEVIN MJ, Ustianowski A, De Wit S, Launay O, et al
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
N Engl J Med. 2022 Apr 20. doi: 10.1056/NEJMoa2116620.
PubMed Abstract available

OFFIT PA
Covid-19 Boosters - Where from Here?
N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMe2203329.
PubMed

MAGEN O, Waxman JG, Makov-Assif M, Vered R, et al
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMoa2201688.
PubMed Abstract available

DRAIN PK
Rapid Diagnostic Testing for SARS-CoV-2. Reply.
N Engl J Med. 2022;386.
PubMed

BOGATY P
Rapid Diagnostic Testing for SARS-CoV-2.
N Engl J Med. 2022;386.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Need a Fourth Dose of Covid Vaccine?
N Engl J Med. 2022;386:e45.
PubMed

MOORE PL, Baden LR
Omicron - Decoupling Infection from Severe Disease.
N Engl J Med. 2022;386:1361-1362.
PubMed

HORWITZ JR, Wiley LF
Not Ready for the End Game - Why Ending Federal Covid-19 Emergency Declarations Will Harm Access to Care.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMp2203468.
PubMed

YOON SK, Hegmann KT, Thiese MS, Burgess JL, et al
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201821.
PubMed

LEE KC, Morgan AU, Chaiyachati KH, Asch DA, et al
Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201541.
PubMed

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
N Engl J Med. 2022 Apr 5. doi: 10.1056/NEJMoa2201570.
PubMed Abstract available

March 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Effectiveness of Covid-19 Vaccination in Children.
N Engl J Med. 2022;386:e39.
PubMed

KLEIN NP
Added Benefit of Covid-19 Vaccination after Previous Infection.
N Engl J Med. 2022;386:1278-1279.
PubMed

REIS G, Silva EASM, Silva DCM, Thabane L, et al
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869.
PubMed Abstract available

SULLIVAN DJ, Gebo KA, Shoham S, Bloch EM, et al
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657.
PubMed Abstract available

PRICE AM, Olson SM, Newhams MM, Halasa NB, et al
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2202826.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19: Why We Publish What We Do.
N Engl J Med. 2022;386:e38.
PubMed

VYAS JM, Castle AC, Bourgouin PP, Turbett SE, et al
Case 9-2022: A 56-Year-Old Woman with Fever, Myalgias, Diarrhea, and Cough.
N Engl J Med. 2022;386:1166-1174.
PubMed

ROSSLER A, Knabl L, von Laer D, Kimpel J, et al
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMc2201607.
PubMed

MOREIRA ED JR, Kitchin N, Xu X, Dychter SS, et al
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMoa2200674.
PubMed Abstract available

QI X, Qiu H, Hao S, Zhu F, et al
Human Infection with an Avian-Origin Influenza A (H10N3) Virus.
N Engl J Med. 2022;386:1087-1088.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Can We Make More Effective Covid-19 Vaccines?
N Engl J Med. 2022;386:e36.
PubMed

DE ANDA C, Johnson MG, Pedley A
Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
N Engl J Med. 2022;386.
PubMed

ROBERFROID D, Jespers V, Hulstaert F
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

LEVENSTEIN S
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

SELVI-SABATER P, Abellon-Ruiz J
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

THORLUND K, Sheldrick K, Mills E
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

REGEV-YOCHAY G, Gonen T, Gilboa M, Mandelboim M, et al
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2202542.
PubMed

SHAPIRO AE, Gupta A
Early Treatment with Sotrovimab for Covid-19. Reply.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

FUJIWARA Y
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

ORIGUEN J, Caro-Teller JM, Lopez-Medrano F
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

HATZL S, Krause R, Schilcher G
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

YU J, Collier AY, Rowe M, Mardas F, et al
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2201849.
PubMed

RUBIN EJ, Baden LR, Hunter D, Morrissey S, et al
Audio Interview: Making Covid-19 Vaccines Available around the World.
N Engl J Med. 2022;386:e31.
PubMed

TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2201933.
PubMed

ROCKETT R, Basile K, Maddocks S, Fong W, et al
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2120219.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
PubMed Abstract available

MONTO AS
The Future of SARS-CoV-2 Vaccination. Reply.
N Engl J Med. 2022;386:899-900.
PubMed

BACHMANN MF, Mohsen MO, Speiser DE
The Future of SARS-CoV-2 Vaccination.
N Engl J Med. 2022;386:899.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly.
N Engl J Med. 2022;386:e29.
PubMed

DOMACHOWSKE J, Madhi SA, Simoes EAF, Atanasova V, et al
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med. 2022;386:892-894.
PubMed

GEE JE, Bower WA, Kunkel A, Petras J, et al
Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.
N Engl J Med. 2022;386:861-868.
PubMed Abstract available

HAMMITT LL, Dagan R, Yuan Y, Baca Cots M, et al
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med. 2022;386:837-846.
PubMed Abstract available

MELLO MM, Parmet WE
U.S. Public Health Law - Foundations and Emerging Shifts.
N Engl J Med. 2022;386:805-808.
PubMed

WALTER EB, Talaat KR, Gurtman A
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
N Engl J Med. 2022;386.
PubMed

LEIBOWITZ R, Schurr E, Hirsch O
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

TAYTARD J, Prevost B, Corvol H
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

ANDREWS N, Stowe J, Kirsebom F, Toffa S, et al
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMoa2119451.
PubMed Abstract available

SAVILLE M, Cramer JP, Downham M, Hacker A, et al
Delivering Pandemic Vaccines in 100 Days - What Will It Take?
N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMp2202669.
PubMed

February 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
N Engl J Med. 2022;386:e27.
PubMed

HUNTER DJ, Abdool Karim SS, Baden LR, Farrar JJ, et al
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.
N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMe2202547.
PubMed

MADHI SA, Kwatra G, Myers JE, Jassat W, et al
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMoa2119658.
PubMed Abstract available

ANDERSON LJ, Walsh EE
The Challenge of Respiratory Syncytial Virus Human Challenge Studies.
N Engl J Med. 2022;386:696-697.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Antiviral against Covid-19.
N Engl J Med. 2022;386:e25.
PubMed

AHMAD A, Eze K, Noulin N, Horvathova V, et al
EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.
N Engl J Med. 2022;386:655-666.
PubMed Abstract available

FLEISHER LA, Schreiber M, Cardo D, Srinivasan A, et al
Health Care Safety during the Pandemic and Beyond - Building a System That Ensures Resilience.
N Engl J Med. 2022;386:609-611.
PubMed

GOTTLIEB RL, Juneja K, Hill JA
Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply.
N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
PubMed

ENNEZAT PV
Outpatient Remdesivir to Prevent Progression to Severe Covid-19.
N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
PubMed

HAMMERMAN A, Sergienko R, Friger M, Beckenstein T, et al
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2119497.
PubMed Abstract available

HALL V, Foulkes S, Insalata F, Kirwan P, et al
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118691.
PubMed Abstract available

HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 as an Endemic Disease.
N Engl J Med. 2022;386:e21.
PubMed

ARBEL R, Sergienko R, Hammerman A
BNT162b2 Vaccine Booster and Covid-19 Mortality. Reply.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2117608.
PubMed Abstract available

PILZ S
BNT162b2 Vaccine Booster and Covid-19 Mortality.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

ROHBAN T
BNT162b2 Vaccine Booster and Covid-19 Mortality.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

ALTARAWNEH HN, Chemaitelly H, Hasan MR, Ayoub HH, et al
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200133.
PubMed

MAYR FB, Talisa VB, Shaikh O, Yende S, et al
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200415.
PubMed

RUBIN EJ, Baden LR, Rosen CJ, Morrissey S, et al
Audio Interview: Studying Long Covid.
N Engl J Med. 2022;386:e20.
PubMed

BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
Calm before the Storm.
N Engl J Med. 2022;386:479-485.
PubMed

MURPHY WJ, Longo DL
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. Reply.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

HARVILLE TO, Arthur JM
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

DE MARIA A
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

BHATTACHARYYA RP, Hanage WP
Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2022 Feb 2. doi: 10.1056/NEJMp2119682.
PubMed

January 2022

RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
N Engl J Med. 2022;386:e16.
PubMed

TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119407.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119432.
PubMed

ROACH A, Chikwe J, Catarino P, Rampolla R, et al
Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2117024.
PubMed

RUBIN EJ, Baden LR, Fineberg HV, Morrissey S, et al
Audio Interview: Crushing the Covid-19 Curve.
N Engl J Med. 2022;386:e13.
PubMed

WALTER EB, Talaat KR, Gurtman A
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
N Engl J Med. 2022;386.
PubMed

MINTZKER Y
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

FANG SF, Liu N, Du HW
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
N Engl J Med. 2022 Jan 19. doi: 10.1056/NEJMc2117933.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Takeaways at Podcast 100.
N Engl J Med. 2022;386:e11.
PubMed

WEINSTEIN DF
Reengineering GME in a Pandemic - Looking Back, and Forward.
N Engl J Med. 2022;386:97.
PubMed

ANDREWS N, Tessier E, Stowe J, Gower C, et al
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2115481.
PubMed Abstract available

EDWARDS KM
Sparing of Severe Covid-19 in Vaccinated Adolescents.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMe2118471.
PubMed

ROSSLER A, Riepler L, Bante D, von Laer D, et al
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMc2119236.
PubMed

OLSON SM, Newhams MM, Halasa NB, Price AM, et al
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117995.
PubMed Abstract available

LIN DY, Gu Y, Wheeler B, Young H, et al
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117128.
PubMed Abstract available

DRAIN PK
Rapid Diagnostic Testing for SARS-CoV-2.
N Engl J Med. 2022 Jan 7. doi: 10.1056/NEJMcp2117115.
PubMed

RUBIN EJ, Baden LR, Drosten C, Morrissey S, et al
Audio Interview: Covid-19 - The Outlook in Europe.
N Engl J Med. 2022;386:e9.
PubMed

GONEN T, Lustig Y, Regev-Yochay G
Covid-19 Infections in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2022;386.
PubMed

RASTMANESH R
Covid-19 Infections in Vaccinated Health Care Workers.
N Engl J Med. 2022;386.
PubMed

EYRE DW, Taylor D, Purver M, Chapman D, et al
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMoa2116597.
PubMed Abstract available

PAI M, Kasaeva T, Swaminathan S
Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.
N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMp2118145.
PubMed

December 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccination and the Omicron Variant.
N Engl J Med. 2021;385:e102.
PubMed

RITTENBERG E
Trust, Faith, and Covid.
N Engl J Med. 2021;385:2504-2505.
PubMed

SCHMIDT F, Muecksch F, Weisblum Y, Da Silva J, et al
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2021 Dec 30. doi: 10.1056/NEJMc2119641.
PubMed

MCGREW S, Taylor HA
Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?
N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMp2116771.
PubMed

NEMET I, Kliker L, Lustig Y, Zuckerman N, et al
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119358.
PubMed

KISSLER SM, Fauver JR, Mack C, Tai CG, et al
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
N Engl J Med. 2021;385:2489-2491.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A Potential New Agent to Treat Covid-19.
N Engl J Med. 2021;385:e101.
PubMed

GENG LN, Verghese A, Tilburt JC
Consultative Medicine - An Emerging Specialty for Patients with Perplexing Conditions.
N Engl J Med. 2021;385:2478-2484.
PubMed

FOXWORTH R, Redvers N, Moreno MA, Lopez-Carmen VA, et al
Covid-19 Vaccination in American Indians and Alaska Natives - Lessons from Effective Community Responses.
N Engl J Med. 2021;385:2403-2406.
PubMed

GOTTLIEB RL, Vaca CE, Paredes R, Mera J, et al
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMoa2116846.
PubMed Abstract available

MUHSEN K, Maimon N, Mizrahi A, Varticovschi B, et al
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2117385.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
N Engl J Med. 2021;385:e100.
PubMed

WHITLEY R
Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19.
N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMe2117814.
PubMed

JAYK BERNAL A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, et al
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMoa2116044.
PubMed Abstract available

CHEMAITELLY H, Bertollini R, Abu-Raddad LJ
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMc2110300.
PubMed

HORTON LE, Abeles SR, Torriani FJ
SARS-CoV-2 Infection in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
PubMed

LILLERI D, Marena C, Baldanti F
SARS-CoV-2 Infection in Vaccinated Health Care Workers.
N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
PubMed

MORENS DM, Taubenberger JK, Fauci AS
Universal Coronavirus Vaccines - An Urgent Need.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMp2118468.
PubMed

DUNKLE LM, Kotloff KL, Gay CL, Anez G, et al
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMoa2116185.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Waning Immunity against SARS-CoV-2.
N Engl J Med. 2021;385:e99.
PubMed

KNUDSEN J, Chokshi DA
Covid-19 and the Safety Net - Moving from Straining to Sustaining.
N Engl J Med. 2021;385:2209-2211.
PubMed

ARBEL R, Hammerman A, Sergienko R, Friger M, et al
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115624.
PubMed Abstract available

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection against Covid-19 by BNT162b2 Booster across Age Groups.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115926.
PubMed Abstract available

WALKER AS, Vihta KD, Gethings O, Pritchard E, et al
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2103227.
PubMed

MCGARRY BE, Barnett ML, Grabowski DC, Gandhi AD, et al
Nursing Home Staff Vaccination and Covid-19 Outcomes.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2115674.
PubMed

RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
Audio Interview: The Omicron Variant of SARS-CoV-2.
N Engl J Med. 2021;385:e96.
PubMed

CAFORIO ALP
Receipt of mRNA Vaccine against Covid-19 and Myocarditis.
N Engl J Med. 2021;385:2189-2190.
PubMed

RUBIN EJ, Longo DL
Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMe2117446.
PubMed

ROSENBERG ES, Dorabawila V, Easton D, Bauer UE, et al
Covid-19 Vaccine Effectiveness in New York State.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2116063.
PubMed Abstract available

DICKERMAN BA, Gerlovin H, Madenci AL, Kurgansky KE, et al
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2115463.
PubMed Abstract available

November 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What's Gone Right in Our Battle against Covid-19.
N Engl J Med. 2021;385:e95.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.
N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMc2108120.
PubMed

MURPHY WJ, Longo DL
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
PubMed

ZARYCHANSKI R, Lawler PR, Goligher E
Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
N Engl J Med. 2021;385:2014.
PubMed

FERNANDES TM, McGuire WC, Morris TA
Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
N Engl J Med. 2021;385:2013.
PubMed

STERPETTI AV
Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
N Engl J Med. 2021;385:2013-2014.
PubMed

RUBIN EJ, Baden LR, Mello MM, Morrissey S, et al
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
N Engl J Med. 2021;385:e88.
PubMed

RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
N Engl J Med. 2021;385:e79.
PubMed

LOPEZ BERNAL J, Gower C, Andrews N
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

EMANI VR, Reddy R, Goswami S
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

LINSENMEYER K, Gupta K, Charness ME
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

TORGOVNICK J
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

MONTO AS
The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
N Engl J Med. 2021;385:e78.
PubMed

SCULLY M
VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

GREINACHER A, Schonborn L, Thiele T
VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

WEBER C, von Hundelshausen P, Siess W
VITT after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

SANTIN AD
VITT after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

URIU K, Kimura I, Shirakawa K, Takaori-Kondo A, et al
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
N Engl J Med. 2021 Nov 3. doi: 10.1056/NEJMc2114706.
PubMed

October 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
N Engl J Med. 2021;385:e74.
PubMed

CHIN MH
Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America.
N Engl J Med. 2021;385:1633-1636.
PubMed

ASKENASE PW
Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
N Engl J Med. 2021;385:1720-1721.
PubMed

GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2107934.
PubMed Abstract available

GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
Waning Immunity after the BNT162b2 Vaccine in Israel.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
PubMed Abstract available

DAGAN N, Barda N, Balicer RD
Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Look at Covid-19 Vaccine Boosters.
N Engl J Med. 2021;385:e72.
PubMed

MALLETT SD
Peak Moments - When Kindergarten Is High Risk.
N Engl J Med. 2021;385:1543-1545.
PubMed

MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
PubMed

TEMPLE C, Hoang R, Hendrickson RG
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114907.
PubMed

CHIN ET, Leidner D, Zhang Y, Long E, et al
Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
PubMed

SHEIKH A, Robertson C, Taylor B
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
PubMed

REIS BY, Barda N, Leshchinsky M, Kepten E, et al
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
PubMed

NOLAN T, Fortanier AC, Leav B, Poder A, et al
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
N Engl J Med. 2021;385:1485-1495.
PubMed Abstract available

RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
Audio Interview: Reporting on Covid-19.
N Engl J Med. 2021;385:e66.
PubMed

HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
N Engl J Med. 2021;385:1511-1520.
PubMed

BALSARI S, Kiang MV, Buckee CO
Data in Crisis - Rethinking Disaster Preparedness in the United States.
N Engl J Med. 2021;385:1526-1530.
PubMed

WHITE EM, Mor V
SARS-CoV-2 Infection among Nursing Home Residents. Reply.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
PubMed

CHANDRASEKAR B
SARS-CoV-2 Infection among Nursing Home Residents.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
PubMed

KORLEY FK, Durkalski-Mauldin V, Callaway CW
Convalescent Plasma for Outpatients with Covid-19. Reply.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

SCHULZ E
Convalescent Plasma for Outpatients with Covid-19.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

FISHER D, Malnick S
Convalescent Plasma for Outpatients with Covid-19.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
N Engl J Med. 2021;385:e63.
PubMed

THOMPSON MG, Grant L, Meece J
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

ZHANG C, Yin G
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

SCHOOLEY RT
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

SANTACATTERINA M, Sanders JW, Weintraub WS
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

O'BRIEN MP, Hou P, Weinreich DM
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
PubMed

MERISON T, Goldman A, Bomze D
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
PubMed

WITBERG G, Barda N, Hoss S, Richter I, et al
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
PubMed Abstract available

MEVORACH D, Anis E, Cedar N, Bromberg M, et al
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
PubMed Abstract available

CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
PubMed Abstract available

LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
PubMed Abstract available

September 2021

RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
Audio Interview: Covid-19 and the Media.
N Engl J Med. 2021;385:e59.
PubMed

RAPEPORT G, Chiu C, McShane H
SARS-CoV-2 Human Challenge Studies. Reply.
N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
PubMed

STEUWER B, Eyal N
SARS-CoV-2 Human Challenge Studies.
N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
PubMed

WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2108163.
PubMed Abstract available

FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
PubMed Abstract available

AMIT S, Gonen T, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2021;385.
PubMed

JUNG J, Sung H, Kim SH
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med. 2021;385.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
N Engl J Med. 2021;385:e54.
PubMed

ESSEX R, Weldon SM
Health Care Worker Strikes and the Covid Pandemic. Reply.
N Engl J Med. 2021;385:e43.
PubMed

CHAN SSC
Health Care Worker Strikes and the Covid Pandemic.
N Engl J Med. 2021;385:e43.
PubMed

SON MBF, Newburger JW, Randolph AG
Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
N Engl J Med. 2021;385:e42.
PubMed

MCARDLE AJ, Cunnington AJ, Levin M
Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
N Engl J Med. 2021;385:e42.
PubMed

OULDALI N, Belot A, Angoulvant F
Therapy for Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:e42.
PubMed

HARLEY JB
Therapy for Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:e42.
PubMed

JONES DS, Podolsky SH
Mask Wars.
N Engl J Med. 2021;385:1159-1161.
PubMed

EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
PubMed Abstract available

PILISHVILI T, Gierke R, Fleming-Dutra KE, Farrar JL, et al
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2106599.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
N Engl J Med. 2021;385:e48.
PubMed

NORTH CS, Sorg EM, Youn S, Chu JT, et al
Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.
N Engl J Med. 2021;385:1125-1132.
PubMed

FRENCK RW JR, Dormitzer PR, Gurtman A
BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
N Engl J Med. 2021;385.
PubMed

LIN CH
BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med. 2021;385.
PubMed

JARA A, Undurraga EA, Araos R
Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
N Engl J Med. 2021;385.
PubMed

ONISHI FJ, Goto JM
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

CHI H, Chiu NC, Lin CY
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

OKHOTIN A
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2114255.
PubMed Abstract available

FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
PubMed

THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting against Severe Disease and Transmission.
N Engl J Med. 2021;385:e44.
PubMed

MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
PubMed

SUN H
On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
PubMed

DEAN NE, Hogan JW, Schnitzer ME
Covid-19 Vaccine Effectiveness and the Test-Negative Design.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
PubMed

THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
PubMed Abstract available

SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
Effect of Vaccination on Transmission of SARS-CoV-2.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Round of Rising Covid-19 Numbers.
N Engl J Med. 2021;385:e41.
PubMed

WILDER-SMITH A, Mulholland K
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385:946-948.
PubMed

WERNER RM, Glied SA
Covid-Induced Changes in Health Care Delivery - Can They Last?
N Engl J Med. 2021;385:868-870.
PubMed

KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
PubMed

MELLO MM, Parmet WE
Public Health Law after Covid-19.
N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMp2112193.
PubMed

August 2021

LEVY JH, Connors JM
Heparin Resistance - Clinical Perspectives and Management Strategies.
N Engl J Med. 2021;385:826-832.
PubMed

PAPINENI P
A Pink Salwar.
N Engl J Med. 2021;385:774-775.
PubMed

LEE GM
The Importance of Context in Covid-19 Vaccine Safety.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
PubMed

BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
PubMed Abstract available

UZUN G, Althaus K, Bakchoul T
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Aspects of Covid-19 Immunity.
N Engl J Med. 2021;385:e31.
PubMed

ROSAS IO, Raby B, Tsai L
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

GORDON AC, Angus DC, Derde LPG
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

BROWN MJ, Alazawi W, Kanoni S
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

TAN CW, Chia WN, Young BE, Zhu F, et al
Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
PubMed Abstract available

KORLEY FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, et al
Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2103784.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Monoclonal Antibodies and Booster Shots.
N Engl J Med. 2021;385:e29.
PubMed

BARAS SHREIBATI J
When Low Tech Wins.
N Engl J Med. 2021;385:581-583.
PubMed

PHILLIPS S, Williams MA
Confronting Our Next National Health Disaster - Long-Haul Covid.
N Engl J Med. 2021;385:577-579.
PubMed

WILLIAMS WW, Ingelfinger JR
Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
PubMed

PAVORD S, Scully M, Hunt BJ, Lester W, et al
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
PubMed Abstract available

ALI K, Berman G, Zhou H, Deng W, et al
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
PubMed Abstract available

HALL VG, Ferreira VH, Ku T, Ierullo M, et al
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
PubMed

COREY L, Beyrer C, Cohen MS, Michael NL, et al
SARS-CoV-2 Variants in Patients with Immunosuppression.
N Engl J Med. 2021;385:562-566.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Looking Back and Looking Forward - Part 2.
N Engl J Med. 2021;385:e25.
PubMed

GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
PubMed Abstract available

LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
PubMed Abstract available

TEN CATE H
Surviving Covid-19 with Heparin?
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
PubMed

O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
PubMed Abstract available

July 2021

GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2021;385:406-415.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Looking Back and Looking Forward - Part 1.
N Engl J Med. 2021;385:e24.
PubMed

BERGWERK M, Gonen T, Lustig Y, Amit S, et al
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
PubMed Abstract available

RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
N Engl J Med. 2021;385:e21.
PubMed

MADHI SA, Izu A, Pollard AJ
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
N Engl J Med. 2021;385.
PubMed

STRUYF F, Sadoff J, Douoguih M
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
N Engl J Med. 2021;385.
PubMed

LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
PubMed Abstract available

RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
PubMed

CHU VT, Yousaf AR, Chang K, Schwartz NG, et al
Household Transmission of SARS-CoV-2 from Children and Adolescents.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMc2031915.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
N Engl J Med. 2021;385:e18.
PubMed

NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
PubMed

DOUGAN M, Nirula A, Azizad M, Mocherla B, et al
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMoa2102685.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Well Are Covid-19 Vaccines Working?
N Engl J Med. 2021;385:e15.
PubMed

EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
PubMed

BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
PubMed

JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Another New Covid-19 Vaccine.
N Engl J Med. 2021;385:e13.
PubMed

SON MBF, Murray N, Friedman K, Young CC, et al
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
N Engl J Med. 2021;385:23-34.
PubMed Abstract available

MCARDLE AJ, Vito O, Patel H, Seaby EG, et al
Treatment of Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:11-22.
PubMed Abstract available

June 2021

THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
PubMed Abstract available

HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New mRNA Vaccine.
N Engl J Med. 2021;384:e109.
PubMed

KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
SARS-CoV-2 Variants and Vaccines.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
PubMed Abstract available

KAMAR N, Abravanel F, Marion O, Couat C, et al
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
PubMed

HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
PubMed

KOENIG PA, Schmidt FI
Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
N Engl J Med. 2021;384:2349-2351.
PubMed

RILEY LE
mRNA Covid-19 Vaccines in Pregnant Women.
N Engl J Med. 2021;384:2342-2343.
PubMed

JAGSI R, Fuentes-Afflick E, Higginbotham E
Promoting Equity for Women in Medicine - Seizing a Disruptive Opportunity.
N Engl J Med. 2021;384:2265-2267.
PubMed

HIBBERT KA, Goiffon RJ, Fogerty AE
Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath.
N Engl J Med. 2021;384:2332-2340.
PubMed

ESSEX R, Weldon SM
Health Care Worker Strikes and the Covid Pandemic.
N Engl J Med. 2021;384:e93.
PubMed

RUBIN EJ, Baden LR, Ingelfinger JR, Morrissey S, et al
Audio Interview: Covid-19 in Children.
N Engl J Med. 2021;384:e108.
PubMed

VANDEBOSCH A, Sadoff J, Douoguih M
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
PubMed

HEININGER U
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
PubMed

SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
PubMed

BECKER SJ, Taylor J, Sharfstein JM
Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMp2103859.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinating Children.
N Engl J Med. 2021;384:e103.
PubMed

BLACHERE NE, Hacisuleyman E, Darnell RB
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

RANA K, Mohindra R, Pinnaka L
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

NIXON DF, Ndhlovu LC
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

May 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting the Immunosuppressed against Covid-19.
N Engl J Med. 2021;384:e88.
PubMed

BURRIS S, Anderson ED, Wagenaar AC
The "Legal Epidemiology" of Pandemic Control.
N Engl J Med. 2021;384:1973-1975.
PubMed

FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
PubMed Abstract available

VOLPP KG, Cannuscio CC
Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
PubMed

SPARROW AK, Brosseau LM, Harrison RJ, Osterholm MT, et al
Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach.
N Engl J Med. 2021 May 25. doi: 10.1056/NEJMp2108567.
PubMed

RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
N Engl J Med. 2021;384:e89.
PubMed

O'CONNELL J, O'Keeffe DT
Contact Tracing for Covid-19 - A Digital Inoculation against Future Pandemics.
N Engl J Med. 2021 May 19. doi: 10.1056/NEJMp2102256.
PubMed

WHITE EM, Yang X, Blackman C, Feifer RA, et al
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
PubMed

RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
Audio Interview: Vaccination and Variants in the U.S. and South Africa.
N Engl J Med. 2021;384:e85.
PubMed

RODRIGUEZ-HERNANDEZ M, Pilato TC, Yerdon KA, Kysel IM, et al
Detained.
N Engl J Med. 2021;384:1785-1787.
PubMed

WAPPNER D, Bergel E, Polack FP
Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

RAGUSA M, Tortosa F, Izcovich A
Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

KLAMT F, Parsons RB, Jones MH
Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

KEEHNER J, Abeles SR, Torriani FJ
More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
PubMed

LIU Y, Liu J, Xia H, Zhang X, et al
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
PubMed

SCALES D, Gorman J, Jamieson KH
The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation.
N Engl J Med. 2021 May 12. doi: 10.1056/NEJMp2103798.
PubMed

RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
Audio Interview: India's Covid-19 Crisis.
N Engl J Med. 2021;384:e84.
PubMed

SALWA J, Robertson C
Designing an Independent Public Health Agency.
N Engl J Med. 2021;384:1684-1687.
PubMed

NEUZIL KM
Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
PubMed

SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
PubMed Abstract available

RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Butt AA
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
PubMed

April 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
N Engl J Med. 2021;384:e77.
PubMed

KADAKIA KT, Beckman AL, Ross JS, Krumholz HM, et al
Leveraging Open Science to Accelerate Research.
N Engl J Med. 2021;384:e61.
PubMed

GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
PubMed

FAJGENBAUM DC, June CH
Cytokine Storm. Reply.
N Engl J Med. 2021;384:e59.
PubMed

MUDD PA, Crawford JC, Thomas PG
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

SUPADY A, Bode C, Duerschmied D
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

GAESTEL M, Nebreda AR, Yaffe MB
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
N Engl J Med. 2021;384:e73.
PubMed

DODD LE, Freidlin B, Korn EL
Platform Trials - Beware the Noncomparable Control Group.
N Engl J Med. 2021;384:1572-1573.
PubMed

CANELLI R, Shrestha GS, Ortega R
Emergency Intubation in Covid-19. Reply.
N Engl J Med. 2021;384.
PubMed

PATEL J, Janapala RN, Pourmand A
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

SELLERS WFS
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

HERZOG N, Giacardi C, Danguy des Deserts M
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

BARDA N, Dagan N, Balicer RD
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
N Engl J Med. 2021;384.
PubMed

ROEST S, Hoek RAS, Manintveld OC
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
N Engl J Med. 2021;384.
PubMed

BAECK M, Marot L, Belkhir L
Delayed Large Local Reactions to mRNA Vaccines.
N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
PubMed

SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
PubMed Abstract available

HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
PubMed Abstract available

CINES DB, Bussel JB
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
PubMed

SCULLY M, Singh D, Lown R, Poles A, et al
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
PubMed Abstract available

MECKLAI K, Smith N, Stern AD, Kramer DB, et al
Remote Patient Monitoring - Overdue or Overused?
N Engl J Med. 2021;384:1384-1386.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccine Successes and Vaccine Adverse Events.
N Engl J Med. 2021;384:e70.
PubMed

LIU Y, Liu J, Xia H, Zhang X, et al
Neutralizing Activity of BNT162b2-Elicited Serum.
N Engl J Med. 2021;384:1466-1468.
PubMed

ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Antibody Responses to Natural Infection and Vaccination.
N Engl J Med. 2021;384:e65.
PubMed

SASISEKHARAN R
Preparing for the Future - Nanobodies for Covid-19?
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMcibr2101205.
PubMed

MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
PubMed

LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
PubMed

SHEN X, Tang H, Pajon R, Smith G, et al
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
PubMed

KIM MC, Park MS, Chung JW
Viable SARS-CoV-2 Shedding. Reply.
N Engl J Med. 2021;384.
PubMed

ROMANO CM, Felix AC, Pannuti CS
Viable SARS-CoV-2 Shedding.
N Engl J Med. 2021;384.
PubMed

DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
PubMed

WANG GL, Wang ZY, Duan LJ, Meng QC, et al
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
PubMed

ELIAS C, Nkengasong JN, Qadri F
Emerging Infectious Diseases - Learning from the Past and Looking to the Future.
N Engl J Med. 2021;384:1181-1184.
PubMed

RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
N Engl J Med. 2021;384:e60.
PubMed

March 2021

QUINN SC, Andrasik MP
Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
PubMed

NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
PubMed

HALL MA, Studdert DM
"Vaccine Passport" Certification - Policy and Ethical Considerations.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
PubMed

RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
N Engl J Med. 2021;384:e55.
PubMed

KADIRE SR, Fabre V, Wenzel RP
Doctor, How Long Should I Isolate?
N Engl J Med. 2021;384:e47.
PubMed

ONI-ORISAN A, Mavura Y, Banda Y, Thornton TA, et al
Embracing Genetic Diversity to Improve Black Health.
N Engl J Med. 2021;384:1163-1167.
PubMed

ABDOOL KARIM SS, de Oliveira T
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
PubMed

ARMSTRONG K
Covid-19 and the Investigator Pipeline.
N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMp2100086.
PubMed

KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
PubMed

BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
PubMed

DANIEL W, Nivet M, Warner J, Podolsky DK, et al
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
N Engl J Med. 2021;384:e53.
PubMed

WU K, Werner AP, Koch M, Choi A, et al
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
PubMed

KRUTIKOV M, Hayward A, Shallcross L
Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMc2035906.
PubMed

MADHI SA, Baillie V, Cutland CL, Voysey M, et al
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
PubMed Abstract available

CARTER S
Breathless.
N Engl J Med. 2021;384:891-893.
PubMed

RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
N Engl J Med. 2021;384:e48.
PubMed

POOLE MK, Fleischhacker SE, Bleich SN
Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
N Engl J Med. 2021;384:e35.
PubMed

KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
PubMed

GORALNICK E, Kaufmann C, Gawande AA
Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
N Engl J Med. 2021;384:e46.
PubMed

GOLETTI D, Cantini F
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
N Engl J Med. 2021;384:867-869.
PubMed

BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
PubMed

STONE JH
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

SALAMA C, Mohan SV
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

LUNDH A
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

STEELFISHER GK, Blendon RJ, Caporello H
An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
PubMed

BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
PubMed

KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
PubMed

LUDVIGSSON JF
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

BESANCON L, Steadson D, Flahault A
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

TAKEFUJI Y
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

February 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
N Engl J Med. 2021;384:e40.
PubMed

NORMAND ST
The RECOVERY Platform.
N Engl J Med. 2021;384:757-758.
PubMed

LANE HC, Fauci AS
Research in the Context of a Pandemic.
N Engl J Med. 2021;384:755-757.
PubMed

MEHROTRA A, Nimgaonkar A, Richman B
Telemedicine and Medical Licensure - Potential Paths for Reform.
N Engl J Med. 2021;384:687-690.
PubMed

VAIS S
The Inequity of Isolation.
N Engl J Med. 2021;384:690-691.
PubMed

ROSAS IO, Brau N, Waters M, Go RC, et al
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2028700.
PubMed Abstract available

GORDON AC, Mouncey PR, Al-Beidh F, Rowan KM, et al
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2100433.
PubMed Abstract available

RUBIN EJ, Longo DL, Baden LR
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMe2103108.
PubMed

DAGAN N, Barda N, Kepten E, Miron O, et al
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
PubMed Abstract available

RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
Audio Interview: Viral Variants and Covid-19.
N Engl J Med. 2021;384:e38.
PubMed

SHRESTHA GS, Shrestha N, Lamsal R, Pradhan S, et al
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384:e20.
PubMed

KADIRE SR, Wachter RM, Lurie N
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
PubMed

ABSALON J, Koury K, Gruber WC
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med. 2021;384.
PubMed

WANG X
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

VERGNES JN
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

SKOWRONSKI DM, De Serres G
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

ROSENBAUM L
Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
PubMed

HARRINGTON DP, Baden LR, Hogan JW
A Large, Simple Trial Leading to Complex Questions.
N Engl J Med. 2021;384:576-577.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
N Engl J Med. 2021;384:e32.
PubMed

HORBY P, White NJ, Landray MJ
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
N Engl J Med. 2021;384.
PubMed

LACOUT A, Perronne C, Lounnas V
Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med. 2021;384.
PubMed

CASTELLS MC, Phillips EJ
Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
PubMed

ROLLA G, Brussino L, Badiu I
Maintaining Safety with SARS-CoV-2 Vaccines.
N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
PubMed

KASPER MR, Geibe JR
An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
N Engl J Med. 2021;384.
PubMed

BYLICKI O, Paleiron N, Janvier F
An Outbreak of Covid-19 on an Aircraft Carrier.
N Engl J Med. 2021;384.
PubMed

RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
N Engl J Med. 2021;384:e25.
PubMed

WYLLIE AL, Vogels CBF, Grubaugh ND
Saliva for Detection of SARS-CoV-2. Reply.
N Engl J Med. 2021;384.
PubMed

MARKEWITZ RDH, Wandinger KP, Junker R
Saliva for Detection of SARS-CoV-2.
N Engl J Med. 2021;384.
PubMed

LUNDGREN JD, Lane HC, Neaton JD
Monoclonal Antibody for Patients with Covid-19. Reply.
N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
PubMed

JAWORSKI JP
Monoclonal Antibody for Patients with Covid-19.
N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
PubMed

January 2021

RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
Audio Interview: A Covid-19 Conversation with Anthony Fauci.
N Engl J Med. 2021;384:e22.
PubMed

HEATON PM
The Covid-19 Vaccine-Development Multiverse. Reply.
N Engl J Med. 2021;384.
PubMed

KOJIMA N, Turner I, Klausner JD
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2021;384.
PubMed

KIM MC, Cui C, Shin KR, Bae JY, et al
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMc2027040.
PubMed

LEE TH, Chen AH
Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
PubMed

COHEN MS
Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.
N Engl J Med. 2021;384:289-291.
PubMed

BOTTI-LODOVICO Y, Rosenberg E, Sabeti PC
Testing in a Pandemic - Improving Access, Coordination, and Prioritization.
N Engl J Med. 2021;384:197-199.
PubMed

RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
Audio Interview: An International Look at Covid-19.
N Engl J Med. 2021;384:e19.
PubMed

PARMET WE
Roman Catholic Diocese of Brooklyn v. Cuomo - The Supreme Court and Pandemic Controls.
N Engl J Med. 2021;384:199-201.
PubMed

KLASS P, Ratner AJ
Vaccinating Children against Covid-19 - The Lessons of Measles.
N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
PubMed

VAN TASSEL K, Shachar C, Hoffman S
Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
PubMed

RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
N Engl J Med. 2021;384:e14.
PubMed

KATZ LM
(A Little) Clarity on Convalescent Plasma for Covid-19.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2035678.
PubMed

JOYNER MJ, Carter RE, Senefeld JW, Klassen SA, et al
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2031893.
PubMed Abstract available

SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
PubMed Abstract available

RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
N Engl J Med. 2021;384:e13.
PubMed

LIBSTER R, Perez Marc G, Wappner D, Coviello S, et al
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMoa2033700.
PubMed Abstract available

LUDVIGSSON JF, Engerstrom L, Nordenhall C, Larsson E, et al
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMc2026670.
PubMed

WOOD S, Schulman K
Beyond Politics - Promoting Covid-19 Vaccination in the United States.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
PubMed

December 2020

MILLER SE
Visualization of SARS-CoV-2 in the Lung.
N Engl J Med. 2020;383:2689.
PubMed

ACKERMANN M, Mentzer SJ, Jonigk D
Visualization of SARS-CoV-2 in the Lung. Reply.
N Engl J Med. 2020;383:2689-2690.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
N Engl J Med. 2020;383:e147.
PubMed

PERRIN JM, Kenney GM, Rosenbaum S
Medicaid and Child Health Equity.
N Engl J Med. 2020;383:2595-2598.
PubMed

CHATTERJEE P, Sommers BD, Joynt Maddox KE
Essential but Undefined - Reimagining How Policymakers Identify Safety-Net Hospitals.
N Engl J Med. 2020;383:2593-2595.
PubMed

RUBIN D, Chan-Tack K, Farley J, Sherwat A, et al
FDA Approval of Remdesivir - A Step in the Right Direction.
N Engl J Med. 2020;383:2598-2600.
PubMed

LEITER RE
Reentry.
N Engl J Med. 2020;383:e141.
PubMed

BADEN LR, Solomon CG, Greene MF, D'Agostino RB, et al
The FDA and the Importance of Trust.
N Engl J Med. 2020;383:e148.
PubMed

NIRULA A, Shen L, Skovronsky DM
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply.
N Engl J Med. 2020;384.
PubMed

CASADEVALL A, Joyner MJ, Pirofski LA
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19.
N Engl J Med. 2020;384.
PubMed

FOPPIANO PALACIOS C, Travassos MA
Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
PubMed

BAROCAS JA
Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
PubMed

BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
PubMed Abstract available

LEE MH, Perl DP, Nair G, Li W, et al
Microvascular Injury in the Brains of Patients with Covid-19.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMc2033369.
PubMed

HAYNES BF
A New Vaccine to Battle Covid-19.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
PubMed

CASTELLS MC, Phillips EJ
Maintaining Safety with SARS-CoV-2 Vaccines.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
PubMed

HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
N Engl J Med. 2020;383:2572-2580.
PubMed

MAITRA A
Holding Up.
N Engl J Med. 2020;383:2498-2499.
PubMed

RITTENBERG E
Sewing Masks - Resilience in the Face of Covid.
N Engl J Med. 2020;383:2497-2498.
PubMed

TAMBYRAJA AL
New Order, New Hope.
N Engl J Med. 2020;383:2495-2496.
PubMed

LUMLEY SF, O'Donnell D, Stoesser NE, Matthews PC, et al
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
N Engl J Med. 2020 Dec 23. doi: 10.1056/NEJMoa2034545.
PubMed Abstract available

STONE JH, Horick NK, Healy BC
Tocilizumab in Covid-19. Reply.
N Engl J Med. 2020;384.
PubMed

LEAF DE, Gupta S, Wang W
Tocilizumab in Covid-19.
N Engl J Med. 2020;384.
PubMed

LUNDGREN JD, Grund B, Barkauskas CE, Holland TL, et al
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med. 2020 Dec 22. doi: 10.1056/NEJMoa2033130.
PubMed Abstract available

CHASTAIN DB, Henao-Martinez AF, Young HN
Racial Disproportionality in Covid Clinical Trials. Reply.
N Engl J Med. 2020;383:2488-2490.
PubMed

TOMASHEK KM, Mehta AK, Hynes NA
Racial Disproportionality in Covid Clinical Trials.
N Engl J Med. 2020;383:2487-2488.
PubMed

GOLDMAN JD, Osinusi A, Marty FM
Racial Disproportionality in Covid Clinical Trials.
N Engl J Med. 2020;383:2486-2487.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccine Fundamentals.
N Engl J Med. 2020;383:e146.
PubMed

HUNTER DJ
Trying to "Protect the NHS" in the United Kingdom.
N Engl J Med. 2020;383:e136.
PubMed

SALAMA C, Han J, Yau L, Reiss WG, et al
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2030340.
PubMed Abstract available

WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2035002.
PubMed Abstract available

BARIC RS
Emergence of a Highly Fit SARS-CoV-2 Variant.
N Engl J Med. 2020 Dec 16. doi: 10.1056/NEJMcibr2032888.
PubMed

KALIL AC, Patterson TF, Mehta AK, Tomashek KM, et al
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med. 2020 Dec 11. doi: 10.1056/NEJMoa2031994.
PubMed Abstract available

RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
N Engl J Med. 2020;383:e143.
PubMed

HUANG E, Jordan SC
Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
N Engl J Med. 2020;383:2387-2388.
PubMed

LEICK MB
Telephone.
N Engl J Med. 2020;383:2304-2305.
PubMed

POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
PubMed Abstract available

RUBIN EJ, Longo DL
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Caring for Hospitalized Patients with Covid-19.
N Engl J Med. 2020;383:e140.
PubMed

FAJGENBAUM DC, June CH
Cytokine Storm.
N Engl J Med. 2020;383:2255-2273.
PubMed

LAHEY T
The Bottom of the Health Care Rationing Iceberg.
N Engl J Med. 2020;383:2200-2201.
PubMed

XING Y, Wong GWK, Ni W, Hu X, et al
Rapid Response to an Outbreak in Qingdao, China.
N Engl J Med. 2020;383:e129.
PubMed

WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
PubMed

CAVALCANTI AB, Berwanger O, Zampieri FG
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

CHOUDHARY R, Bohra GK, Kumar D
Hydroxychloroquine with or without Azithromycin in Covid-19.
N Engl J Med. 2020;383.
PubMed

KEANE MJ
Hydroxychloroquine with or without Azithromycin in Covid-19.
N Engl J Med. 2020;383.
PubMed

PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
PubMed Abstract available

AYDILLO T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
N Engl J Med. 2020 Dec 1. doi: 10.1056/NEJMc2031670.
PubMed

November 2020

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: New Studies of Covid-19 Transmission.
N Engl J Med. 2020;383:e138.
PubMed

KATZ DH, Wilson JG, Gerszten RE
Mining a GWAS of Severe Covid-19.
N Engl J Med. 2020;383.
PubMed

KARIM M, Ghoussaini M, Dunham I
Mining a GWAS of Severe Covid-19.
N Engl J Med. 2020;383.
PubMed

KENNEDY BS, Richeson RP, Houde AJ
Risk Factors for SARS-CoV-2 in a Statewide Correctional System.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMc2029354.
PubMed

MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
PubMed Abstract available

SIMONOVICH VA, Burgos Pratx LD, Scibona P, Beruto MV, et al
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2031304.
PubMed Abstract available

MANZANO GS, Woods JK, Amato AA
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.
PubMed

RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
Audio Interview: Covid-19 in Europe and New Information on Vaccines.
N Engl J Med. 2020;383:e134.
PubMed

MALINA S, Warbelow S, Radix AE
Two Steps Back - Rescinding Transgender Health Protections in Risky Times.
N Engl J Med. 2020;383:e116.
PubMed

RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
Audio Interview: An Update from Operation Warp Speed.
N Engl J Med. 2020;383:e127.
PubMed

CHOI B, Choudhary MC, Regan J, Sparks JA, et al
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
PubMed

MICHAEL NL
SARS-CoV-2 in the U.S. Military - Lessons for Civil Society.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMe2032179.
PubMed

LETIZIA AG, Ramos I, Obla A, Goforth C, et al
SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2029717.
PubMed Abstract available

KASPER MR, Geibe JR, Sears CL, Riegodedios AJ, et al
An Outbreak of Covid-19 on an Aircraft Carrier.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2019375.
PubMed Abstract available

DOLIN R, Hirsch MS
Remdesivir - An Important First Step.
N Engl J Med. 2020;383:1886-1887.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
N Engl J Med. 2020;383:e123.
PubMed

MATIAS WR, Vaidya A, Brigl M, Bebell LM, et al
A Patient with Fever and Dyspnea.
N Engl J Med. 2020;383:e111.
PubMed

GUDBJARTSSON DF, Stefansson K
Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
N Engl J Med. 2020;383.
PubMed

COWIE BC, MacLachlan JH
Early Spread of SARS-CoV-2 in the Icelandic Population.
N Engl J Med. 2020;383.
PubMed

October 2020

LEVIN M
Multisystem Inflammatory Syndrome in Children in the United States. Reply.
N Engl J Med. 2020;383:1795-1796.
PubMed

FELDSTEIN LR, Rose EB, Randolph AG
Multisystem Inflammatory Syndrome in Children in the United States. Reply.
N Engl J Med. 2020;383:1794-1795.
PubMed

ARDITI M, Bahar I
Multisystem Inflammatory Syndrome in Children in the United States.
N Engl J Med. 2020;383:1794.
PubMed

ALTER G, Seder R
The Power of Antibody-Based Surveillance.
N Engl J Med. 2020;383:1782-1784.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Monoclonal Antibody for Covid-19.
N Engl J Med. 2020;383:e117.
PubMed

WU K, Smith CR, Lembcke BT, Ferreira TBD, et al
Elective Surgery during the Covid-19 Pandemic.
N Engl J Med. 2020;383:1787-1790.
PubMed

BLENDON RJ, Benson JM
Implications of the 2020 Election for U.S. Health Policy.
N Engl J Med. 2020;383:e105.
PubMed

CAHAN EM, Levine LB, Chin WW
The Human Touch - Addressing Health Care's Workforce Problem amid the Pandemic.
N Engl J Med. 2020;383:e102.
PubMed

DEFOREST A
The New Stability.
N Engl J Med. 2020;383:1708-1709.
PubMed

HALABI S, Heinrich A, Omer SB
No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
PubMed

CHEN P, Nirula A, Heller B, Gottlieb RL, et al
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMoa2029849.
PubMed Abstract available

REYNOLDS HR, Adhikari S, Iturrate E
RAAS Inhibitors and Risk of Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

MANCIA G, Rea F, Corrao G
RAAS Inhibitors and Risk of Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

STRAUSS MH, Hall AS, Lavie CJ
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

ISLAM N, Khunti K, Chowell G
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

SRIRAM K, Loomba R, Insel PA
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

ANGELI F, Verdecchia P, Reboldi G
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

GANDHI M, Rutherford GW
Facial Masking for Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

BROSSEAU LM, Roy CJ, Osterholm MT
Facial Masking for Covid-19.
N Engl J Med. 2020;383.
PubMed

RASMUSSEN AL, Escandon K, Popescu SV
Facial Masking for Covid-19.
N Engl J Med. 2020;383.
PubMed

PLATTON S, Bowles L, Pasi KJ
Lupus Anticoagulant in Patients with Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

GOODING R, Myers B, Salta S
Lupus Anticoagulant in Patients with Covid-19.
N Engl J Med. 2020;383.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Tocilizumab and Covid-19.
N Engl J Med. 2020;383:e114.
PubMed

CHOWDHURY JF, Moores LK, Connors JM
Anticoagulation in Hospitalized Patients with Covid-19.
N Engl J Med. 2020;383:1675-1678.
PubMed

ROSENBAUM L
Tribal Truce - How Can We Bridge the Partisan Divide and Conquer Covid?
N Engl J Med. 2020;383:1682-1685.
PubMed

WILENSKY GR
Policy Lessons from Our Covid Experience.
N Engl J Med. 2020;383:e96.
PubMed

AGARWAL SD, Sommers BD
Insurance Coverage after Job Loss - The Importance of the ACA during the Covid-Associated Recession.
N Engl J Med. 2020;383:1603-1606.
PubMed

BELOT A, Levy-Bruhl D
Multisystem Inflammatory Syndrome in Children in the United States.
N Engl J Med. 2020;383.
PubMed

STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
PubMed

STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
PubMed Abstract available

RAFIEI Y, Mello MM
The Missing Piece - SARS-CoV-2 Testing and School Reopening.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.
PubMed

KRAUSE PR, Gruber MF
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
PubMed

WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
PubMed

KASER A
Genetic Risk of Severe Covid-19.
N Engl J Med. 2020;383:1590-1591.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinology and Covid-19.
N Engl J Med. 2020;383:e109.
PubMed

GLIED S
Health Policy in a Biden Administration.
N Engl J Med. 2020;383:1501-1503.
PubMed

WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
PubMed Abstract available

SHAPIRO J, McDonald TB
Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 and the President.
N Engl J Med. 2020;383:e104.
PubMed

Dying in a Leadership Vacuum.
N Engl J Med. 2020;383:1479-1480.
PubMed

HORBY P, Mafham M, Linsell L, Bell JL, et al
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926.
PubMed Abstract available

CELUM C, Barnabas R, Cohen MS, Collier A, et al
Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
PubMed

PAGE KR, Flores-Miller A
Lessons We've Learned - Covid-19 and the Undocumented Latinx Community.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2024897.
PubMed

ROSENQUIST JN
The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2018857.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Testing and the Individual Physician.
N Engl J Med. 2020;383:e99.
PubMed

HATA SR
The Ritual of the Table.
N Engl J Med. 2020;383:1301-1303.
PubMed

September 2020

RASMUSSEN SA, Lyerly AD, Jamieson DJ
Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.
PubMed

MINA MJ, Parker R, Larremore DB
Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631.
PubMed

ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Eight Months of Action and Inaction against Covid-19.
N Engl J Med. 2020;383:e95.
PubMed

CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
Ebola Response Priorities in the Time of Covid-19.
N Engl J Med. 2020;383:1202-1204.
PubMed

CUNEO CN, Janeway H
From Icebox to Tinderbox - A View from the Southern Border.
N Engl J Med. 2020;383:e81.
PubMed

YANG OO, Ibarrondo FJ
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

KUTSUNA S, Asai Y, Matsunaga A
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

TERPOS E, Mentis A, Dimopoulos MA
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

BOLKE E, Matuschek C, Fischer JC
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

SCHWARTZ JL
Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
PubMed

PERETZ PJ, Islam N, Matiz LA
Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond.
N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2022641.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
N Engl J Med. 2020;383:e92.
PubMed

FISHMAN JA, Roberts MB, Zhang EW, Kumar D, et al
Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation.
N Engl J Med. 2020;383:1168-1180.
PubMed

JOUNG J, Ladha A, Saito M, Kim NG, et al
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.
N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMc2026172.
PubMed

EVANS ML, Lindauer M, Farrell ME
A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19.
N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046.
PubMed

AVORN J, Kesselheim AS
Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2029479.
PubMed

SLAOUI M, Greene SE, Woodcock J
Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.
N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2028535.
PubMed

EVANS MK
Health Equity - Are We Finally on the Edge of a New Frontier?
N Engl J Med. 2020;383:997-999.
PubMed

GOLDHAMER MEJ, Pusic MV, Co JPT, Weinstein DF, et al
Can Covid Catalyze an Educational Transformation? Competency-Based Advancement in a Crisis.
N Engl J Med. 2020;383:1003-1005.
PubMed

SHUREN J, Stenzel T
Covid-19 Molecular Diagnostic Testing - Lessons Learned.
N Engl J Med. 2020 Sep 9. doi: 10.1056/NEJMp2023830.
PubMed

GANDHI M, Rutherford GW
Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
PubMed

BLOOM BR, Nowak GJ, Orenstein W
"When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.
PubMed

KEECH C, Albert G, Cho I, Robertson A, et al
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
PubMed Abstract available

GUDBJARTSSON DF, Norddahl GL, Melsted P, Gunnarsdottir K, et al
Humoral Immune Response to SARS-CoV-2 in Iceland.
N Engl J Med. 2020 Sep 1. doi: 10.1056/NEJMoa2026116.
PubMed Abstract available

August 2020

WYLLIE AL, Fournier J, Casanovas-Massana A, Campbell M, et al
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
N Engl J Med. 2020 Aug 28. doi: 10.1056/NEJMc2016359.
PubMed

SLAOUI M, Hepburn M
Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
N Engl J Med. 2020 Aug 26. doi: 10.1056/NEJMp2027405.
PubMed

HORN DM, Haas JS
Covid-19 and the Mandate to Redefine Preventive Care.
N Engl J Med. 2020 Aug 12. doi: 10.1056/NEJMp2018749.
PubMed

STUDDERT DM, Hall MA, Mello MM
Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.
N Engl J Med. 2020 Aug 5. doi: 10.1056/NEJMp2024274.
PubMed

July 2020

CORBETT KS, Flynn B, Foulds KE, Francica JR, et al
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med. 2020 Jul 28. doi: 10.1056/NEJMoa2024671.
PubMed Abstract available

CAVALCANTI AB, Zampieri FG, Rosa RG, Azevedo LCP, et al
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMoa2019014.
PubMed Abstract available

BERKOWITZ SA, Cene CW, Chatterjee A
Covid-19 and Health Equity - Time to Think Big.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2021209.
PubMed

EGEDE LE, Walker RJ
Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2023616.
PubMed

BLUMENTHAL D, Fowler EJ, Abrams M, Collins SR, et al
Covid-19 - Implications for the Health Care System.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMsb2021088.
PubMed

HORBY P, Lim WS, Emberson JR, Mafham M, et al
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436.
PubMed Abstract available

NORTH CM, Dougan ML, Sacks CA
Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.
N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2019989.
PubMed

JACKSON LA, Anderson EJ, Rouphael NG, Roberts PC, et al
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMoa2022483.
PubMed Abstract available

HEATON PM
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMe2025111.
PubMed

June 2020

MELLO MM, Silverman RD, Omer SB
Ensuring Uptake of Vaccines against SARS-CoV-2.
N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020926.
PubMed

ELLINGHAUS D, Degenhardt F, Bujanda L, Buti M, et al
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med. 2020 Jun 17. doi: 10.1056/NEJMoa2020283.
PubMed Abstract available

May 2020

GOLDMAN JD, Lye DCB, Hui DS, Marks KM, et al
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301.
PubMed Abstract available

BEIGEL JH, Tomashek KM, Dodd LE, Mehta AK, et al
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764.
PubMed Abstract available

BERLIN DA, Gulick RM, Martinez FJ
Severe Covid-19.
N Engl J Med. 2020 May 15. doi: 10.1056/NEJMcp2009575.
PubMed

April 2020

GANDHI RT, Lynch JB, Del Rio C
Mild or Moderate Covid-19.
N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMcp2009249.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: